IN8bio (INAB)
NASDAQ:INAB
Want to see INAB full AI Analyst Report?
Total Valuation
IN8bio has a market cap or net worth of $13.98M. The enterprise value is -$12.87M.
Market Cap$13.98M
Enterprise Value-$12.87M
Share Statistics
IN8bio has 9,847,089 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding9,847,089
Owned by Insiders12.40%
Owned by Institutions25.63%
Financial Efficiency
IN8bio’s return on equity (ROE) is -0.71 and return on invested capital (ROIC) is -65.46%.
Return on Equity (ROE)-0.71
Return on Assets (ROA)-0.60
Return on Invested Capital (ROIC)-65.46%
Return on Capital Employed (ROCE)-0.68
Revenue Per Employee0.00
Profits Per Employee-1.08M
Employee Count18
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of IN8bio is ―. IN8bio’s PEG ratio is -0.00078.
PE Ratio―
PS Ratio0.00
PB Ratio0.37
Price to Fair Value0.37
Price to FCF-0.81
Price to Operating Cash Flow-0.44
PEG Ratio-0.00078
Income Statement
In the last 12 months, IN8bio had revenue of 0.00 and earned -19.44M in profits. Earnings per share was -4.44.
Revenue0.00
Gross Profit-2.50M
Operating Income-19.86M
Pretax Income-19.44M
Net Income-19.44M
EBITDA-17.36M
Earnings Per Share (EPS)-4.44
Cash Flow
In the last 12 months, operating cash flow was -14.54M and capital expenditures -9.00K, giving a free cash flow of -14.55M billion.
Operating Cash Flow-14.54M
Free Cash Flow-14.55M
Free Cash Flow per Share-1.48
Dividends & Yields
IN8bio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.75
52-Week Price Change-61.64%
50-Day Moving Average1.57
200-Day Moving Average1.90
Relative Strength Index (RSI)42.59
Average Volume (3m)74.58K
Important Dates
IN8bio upcoming earnings date is Aug 6, 2026, After Close (Confirmed).
Last Earnings DateMay 7, 2026
Next Earnings DateAug 6, 2026
Ex-Dividend Date―
Financial Position
IN8bio as a current ratio of 8.82, with Debt / Equity ratio of 10.33%
Current Ratio8.82
Quick Ratio8.82
Debt to Market Cap0.27
Net Debt to EBITDA1.40
Interest Coverage Ratio0.00
Taxes
In the past 12 months, IN8bio has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
IN8bio EV to EBITDA ratio is 0.81, with an EV/FCF ratio of 1.11.
EV to Sales0.00
EV to EBITDA0.81
EV to Free Cash Flow1.11
EV to Operating Cash Flow1.11
Balance Sheet
IN8bio has $21.94M in cash and marketable securities with $2.35M in debt, giving a net cash position of $19.59M billion.
Cash & Marketable Securities$21.94M
Total Debt$2.35M
Net Cash$19.59M
Net Cash Per Share$1.99
Tangible Book Value Per Share$6.30
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for IN8bio is $5.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$5.00
Price Target Upside247.22% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast―
EPS Growth Forecast80.68%